https://orcid.org/0000-0002-9477-1492
Overview
I am a pediatric infectious disease specialist and pediatric clinical researcher. My research interests are centered around finding the optimal ways to manage infections and minimize harms to patients. Recognizing the growing global threat of antibiotic resistance, I am particularly interested in finding the right dose and duration of antibiotics that children should receive to treat their infections, and studying the epidemiology and prevention of antibiotic resistant infections.
Current Appointments & Affiliations
Assistant Professor of Pediatrics
·
2023 - Present
Pediatrics, Infectious Diseases,
Pediatrics
Member in the Duke Clinical Research Institute
·
2023 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Evaluating the duration of post-discontinuation therapeutic ampicillin exposures in preterm infants.
Journal Article J Perinatol · March 13, 2026 OBJECTIVE: Determine if preterm infants have prolonged therapeutic post-discontinuation antibiotic exposures (PDAE) following empiric ampicillin. STUDY DESIGN: Prospective study of 27 infants ≤7 days and <37 weeks gestational age (GA) receiving ampicillin ... Full text Link to item CiteEscherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
Journal Article Clin Infect Dis · March 6, 2026 BACKGROUND: Ceftriaxone-resistant Escherichia coli infections are increasingly common, partially due to the emergence of E. coli sequence type 131 (ST131) including its subclade C2/H30Rx that produce extended-spectrum β-lactamases (ESBL). METHODS: A prospe ... Full text Link to item CiteMpox epidemiology, barriers to treatment and prevention, and perceived stigma: a cross-sectional study.
Journal Article BMC Public Health · September 30, 2025 BACKGROUND: The 2022 mpox outbreak in the United States primarily affected sexual minority men. Barrier to healthcare access, treatment, and vaccination against mpox are not well characterized. Stigma surrounding mpox has not been well quantified, and may ... Full text Link to item CiteRecent Grants
Combating Related Epidemics in HCV through Simplified Testing and Treatment (CREST). A cluster randomized trial of point-of-care hepatitis C testing and treatment among key populations
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030Short-course ampicillin in preterm neonates to promote antimicrobial stewardship
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2029BPCA Concept Development, Investigator Development and Clinical Trial Readiness Support (Version 2.0) - Option Period 1
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2025View All Grants
Education
University of North Carolina, Chapel Hill ·
2023
M.P.H.
University of Florida, College of Medicine ·
2017
M.D.